Preferential activation of type I interferon-mediated antitumor inflammatory signaling by CuS/MnO2/diAMP nanoparticles enhances anti-PD-1 therapy for sporadic colorectal cancer

Jinrong Peng(Sichuan University), Zhiyong Qian(Sichuan University), Qian Yang(Hebei University of Engineering), G. Liu(Chengdu Medical College), Rong Lei(Sun Yat-sen University), Yue Wang(Shanghai Medical College of Fudan University)
Journal of Nanobiotechnology
November 12, 2024
10.1186/s12951-024-02970-y
Cited by 11

Related Papers

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
|Cell|2016|1.1k
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
|Blood|2013|537
Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages
|Cell Research|2010|216
Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin e6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy
|Theranostics|2018|212
A biodegradable thermo-responsive hybrid hydrogel: therapeutic applications in preventing the post-operative recurrence of breast cancer
|NPG Asia Materials|2015|134